BIOMARCADORES NO DIAGNÓSTICO E PROGNÓSTICO DA OSTEONECROSE DOS MAXILARES RELACIONADA A MEDICAMENTOS — REVISÃO DE LITERATURA
Bruna Mabilly Dias, Carla Regina Massaro, Leonardo Henrique Silva Machado, Ana Karolina Matos, Yohana Rafaela Reticena · 2026
Read BIOMARCADORES NO DIAGNÓSTICO E PROGNÓSTICO DA OSTEONECROSE DOS MAXILARES RELACIONADA A MEDICAMENTOS — REVISÃO DE LITERATURA by Bruna Mabilly Dias, Carla Regina Massaro, Leonardo Henrique Silva Machado, Ana Karolina Matos, Yohana Rafaela Reticena (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/openalex-w7214010372.txt.
Description
Bruna Mabilly Dias leads a literature review on biomarkers for drug-related jaw bone death. That grave complication is tied mainly to bone-protecting drugs such as bisphosphonates and denosumab, and to some anti-vessel agents. Exposed jaw bone, without prior jaw radiotherapy, defines the condition.
Diagnosis still rests on drug history, clinical examination, and imaging, the review notes. Candidate markers cover bone turnover, bone formation, inflammation, vessel growth, proteins, genes, and microRNAs. Results across studies are mixed, they find. No single marker yet predicts or confirms the disease reliably on its own. Biomarkers remain complementary tools while the search for a dependable test continues.
Catalog record
| CREATOR | Bruna Mabilly Dias, Carla Regina Massaro, Leonardo Henrique Silva Machado, Ana Karolina Matos, Yohana Rafaela Reticena |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 42 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | OpenAlex / Revista Ibero-Americana de Humanidades, Ciências e Educação |